Real-world experience with pembrolizumab in patients with advanced soft tissue sarcoma

BACKGROUND: The goal of this study was to retrospectively analyze the efficacy and safety of pembrolizumab in the real-world treatment of soft tissue sarcoma (STS). METHODS: We analyzed 38 patients who suffered from STS and received pembrolizumab treatment from July 2017 to December 2018 in our hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiayong, Fan, Zhengfu, Bai, Chujie, Li, Shu, Xue, Ruifeng, Gao, Tian, Zhang, Lu, Tan, Zhichao, Fang, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944271/
https://www.ncbi.nlm.nih.gov/pubmed/33708966
http://dx.doi.org/10.21037/atm-21-49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944271/
https://www.ncbi.nlm.nih.gov/pubmed/33708966
http://dx.doi.org/10.21037/atm-21-49

Ejemplares similares